ARYX ARYx Therapeutics, Inc.

[greencat]

ARYX has a rounded bottom after a heavy fall- Bounce play-on these kind of plays don't get greedy and lock in profits if able. Save a few free shares in case it bounces hard. Can not make a lower low- that would be my cut loss point.

ARYX chart


ARYx Therapeutics, Inc.
6300 Dumbarton Circle
Fremont, CA 94555
United States - Map
Phone: 510-585-2200
Fax: 510-585-2202
Web Site: ARYx Therapeutics

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Drug Manufacturers - Other
Full Time Employees: 56


BUSINESS SUMMARY
ARYx Therapeutics, Inc., a biopharmaceutical company, focuses on developing a portfolio of product candidates designed to eliminate known safety issues associated with commercial drugs using its RetroMetabolic Drug Design technology. Its product portfolio includes tecarfarin, an oral anticoagulant in Phase II/III clinical development for the treatment of patients who are at risk for the formation of dangerous blood clots; budiodarone/ATI-2042, an oral antiarrhythmic agent in Phase II clinical development for the treatment of atrial fibrillation, a form of irregular heartbeat; ATI-7505, an oral prokinetic agent in Phase II clinical development for the treatment of chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease; and ATI-9242, an antipsychotic agent in Phase I clinical development for the treatment of schizophrenia and other psychiatric disorders. The company also involves in the preclinical development of ATI-20,000 and ATI-24,000, which focus on metabolic and gastrointestinal disorders. ARYx Therapeutics, Inc. was incorporated in 1997 and is based in Fremont, California.